SCHEMBL8684133

SCHEMBL8684133

CCOCn1c(CCCCC(C)(C)O)nc2c1c(=O)[nH]c(=O)n2C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
HPGD P15428 4/20 0.47
MAPK1 P28482 4/20 0.46
HSD17B10 Q99714 2/20 0.46
CYP2C9 P11712 3/20 0.44
NPSR1 Q6W5P4 3/20 0.44
MEN1 O00255 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.42
TSHR P16473 2/20 0.42
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
HTT P42858 1/20 0.41
GAA P10253 1/20 0.41
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7855217 0.87 HPGD (0.53) ALDH1A1HPGDMAPK1HSD17B10CYP2C9
SCHEMBL5088230 0.83 SMN1; SMN2 (0.45) ALDH1A1HPGDMAPK1HSD17B10CYP2C9
SCHEMBL4705592 0.74 KDM4E (0.62) ALDH1A1HPGDMAPK1CYP2C9MEN1
SCHEMBL19976357 0.74 ALDH1A1 (0.57) ALDH1A1HPGDMAPK1HSD17B10CYP2C9
SCHEMBL9171903 0.73 MAPT (0.47) ALDH1A1HPGDMAPK1CYP2C9NPSR1
SCHEMBL5093687 0.70 HPGD (0.54) ALDH1A1HPGDMAPK1HSD17B10CYP2C9
SCHEMBL9721364 0.70 HPGD (0.53) ALDH1A1HPGDMAPK1HSD17B10CYP2C9
SCHEMBL8646400 0.69 ALDH1A1 (0.50) ALDH1A1HPGDMAPK1HSD17B10CYP2C9
SCHEMBL5093657 0.69 CYP2C19 (0.48) ALDH1A1MAPK1HSD17B10NPSR1CYP3A4
SCHEMBL9298051 0.69 ALDH1A1 (0.47) ALDH1A1HPGDMAPK1CYP2C9NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3242668-A1 PHARMACEUTICAL FORMULATIONS OF XANTHINE OR XANTHINE DERIVATIVES Imprimis Pharmaceuticals Inc. (US) 2017-11-15 EP disclosed
WO-2016111885-A1 PHARMACEUTICAL FORMULATIONS OF XANTHINE OR XANTHINE DERIVATIVES IMPRIMIS PHARMACEUTICALS, INC. (US) 2016-07-14 WO disclosed
WO-1998030900-A2 SCREENING METHOD FOR COMPOUNDS ACTIVE IN TREATING MYOPIA AND HYPERMETROPIA KLAUS TRIER APS (DK) 1998-07-16 WO disclosed
EP-0669825-A4 HYDROXYL-CONTAINING COMPOUNDS. CELL THERAPEUTICS INC (US) 1996-04-03 EP disclosed
EP-0669825-A1 HYDROXYL-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1995-09-06 EP disclosed
WO-1994011001-A1 HYDROXYL-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-05-26 WO disclosed